+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Antibiotics Market 2023-2027

  • PDF Icon

    Report

  • 163 Pages
  • December 2022
  • Region: Global
  • TechNavio
  • ID: 5007834
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The antibiotics market is poised to grow by $17066.66 mn during 2022-2027, accelerating at a CAGR of 6.07% during the forecast period. The report on the antibiotics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the rising prevalence of infectious diseases, growing awareness of various diseases and their treatment, and special regulatory designations.

The antibiotics market is segmented as below:

By Route Of Administration

  • Intravenous
  • Oral
  • Others

By Product

  • Broad-spectrum antibiotics
  • Narrow-spectrum antibiotics

By Geographical Landscape

  • Asia
  • North America
  • Europe
  • Rest of World (ROW)
This study identifies strategic alliances and mergers and acquisitions (M&A) as one of the prime reasons driving the antibiotics market growth during the next few years. Also, the presence of patient assistance programs (PAPS) and increased federal and institutional funding for antibiotic research will lead to sizable demand in the market.

The report on the antibiotics market covers the following areas:

  • Antibiotics market sizing
  • Antibiotics market forecast
  • Antibiotics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading antibiotics market vendors that include Abbott Laboratories, AbbVie Inc., Armata Pharmaceuticals Inc., Aspen Pharmacare Holdings Ltd, Astellas Pharma Inc., Aurobindo Pharma Ltd., Bayer AG, F. Hoffmann La Roche Ltd., Flynn Pharma Ltd., GlaxoSmithKline Plc, Incepta Pharmaceuticals Ltd., Johnson and Johnson, Lupin Ltd., Mayne Pharma Group Ltd., Melinta Therapeutics LLC, Merck KGaA, Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd. Also, the antibiotics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Product
Exhibit 06: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
4.1 Global antibiotics market 2022 - 2027
Exhibit 18: Historic Market Size - Data Table on Global antibiotics market 2022 - 2027 ($ million)
4.2 Product Segment Analysis 2022 - 2027
Exhibit 19: Historic Market Size - Product Segment 2022 - 2027 ($ million)
4.3 Route of administration Segment Analysis 2022 - 2027
Exhibit 20: Historic Market Size - Route of administration Segment 2022 - 2027 ($ million)
4.4 Geography Segment Analysis 2022 - 2027
Exhibit 21: Historic Market Size - Geography Segment 2022 - 2027 ($ million)
4.5 Country Segment Analysis 2022 - 2027
Exhibit 22: Historic Market Size - Country Segment 2022 - 2027 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Product
6.1 Market segments
Exhibit 30: Chart on Product - Market share 2022-2027 (%)
Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
6.2 Comparison by Product
Exhibit 32: Chart on Comparison by Product
Exhibit 33: Data Table on Comparison by Product
6.3 Broad-spectrum antibiotics - Market size and forecast 2022-2027
Exhibit 34: Chart on Broad-spectrum antibiotics - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Broad-spectrum antibiotics - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Broad-spectrum antibiotics - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Broad-spectrum antibiotics - Year-over-year growth 2022-2027 (%)
6.4 Narrow-spectrum antibiotics - Market size and forecast 2022-2027
Exhibit 38: Chart on Narrow-spectrum antibiotics - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Narrow-spectrum antibiotics - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Narrow-spectrum antibiotics - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Narrow-spectrum antibiotics - Year-over-year growth 2022-2027 (%)
6.5 Market opportunity by Product
Exhibit 42: Market opportunity by Product ($ million)
7 Market Segmentation by Route of Administration
7.1 Market segments
Exhibit 43: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibit 44: Data Table on Route of Administration - Market share 2022-2027 (%)
7.2 Comparison by Route of Administration
Exhibit 45: Chart on Comparison by Route of Administration
Exhibit 46: Data Table on Comparison by Route of Administration
7.3 Intravenous - Market size and forecast 2022-2027
Exhibit 47: Chart on Intravenous - Market size and forecast 2022-2027 ($ million)
Exhibit 48: Data Table on Intravenous - Market size and forecast 2022-2027 ($ million)
Exhibit 49: Chart on Intravenous - Year-over-year growth 2022-2027 (%)
Exhibit 50: Data Table on Intravenous - Year-over-year growth 2022-2027 (%)
7.4 Oral - Market size and forecast 2022-2027
Exhibit 51: Chart on Oral - Market size and forecast 2022-2027 ($ million)
Exhibit 52: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibit 54: Data Table on Oral - Year-over-year growth 2022-2027 (%)
7.5 Others - Market size and forecast 2022-2027
Exhibit 55: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 56: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibit 58: Data Table on Others - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by Route of Administration
Exhibit 59: Market opportunity by Route of Administration ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibit 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
9.2 Geographic comparison
Exhibit 63: Chart on Geographic comparison
Exhibit 64: Data Table on Geographic comparison
9.3 Asia - Market size and forecast 2022-2027
Exhibit 65: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 66: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 67: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 68: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.4 North America - Market size and forecast 2022-2027
Exhibit 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 71: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.5 Europe - Market size and forecast 2022-2027
Exhibit 73: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 74: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 84: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 85: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 86: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 87: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 88: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 India - Market size and forecast 2022-2027
Exhibit 89: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibit 90: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibit 91: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibit 92: Data Table on India - Year-over-year growth 2022-2027 (%)
9.10 UK - Market size and forecast 2022-2027
Exhibit 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.11 Japan - Market size and forecast 2022-2027
Exhibit 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibit 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibit 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 101: Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 102: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 103: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 104: Overview on factors of disruption
11.4 Industry risks
Exhibit 105: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 106: Vendors covered
12.2 Market positioning of vendors
Exhibit 107: Matrix on vendor position and classification
12.3 Abbott Laboratories
Exhibit 108: Abbott Laboratories - Overview
Exhibit 109: Abbott Laboratories - Business segments
Exhibit 110: Abbott Laboratories - Key news
Exhibit 111: Abbott Laboratories - Key offerings
Exhibit 112: Abbott Laboratories - Segment focus
12.4 AbbVie Inc.
Exhibit 113: AbbVie Inc. - Overview
Exhibit 114: AbbVie Inc. - Product/Service
Exhibit 115: AbbVie Inc. - Key news
Exhibit 116: AbbVie Inc. - Key offerings
12.5 Aspen Pharmacare Holdings Ltd
Exhibit 117: Aspen Pharmacare Holdings Ltd - Overview
Exhibit 118: Aspen Pharmacare Holdings Ltd - Business segments
Exhibit 119: Aspen Pharmacare Holdings Ltd - Key offerings
Exhibit 120: Aspen Pharmacare Holdings Ltd - Segment focus
12.6 Astellas Pharma Inc.
Exhibit 121: Astellas Pharma Inc. - Overview
Exhibit 122: Astellas Pharma Inc. - Product/Service
Exhibit 123: Astellas Pharma Inc. - Key offerings
12.7 Aurobindo Pharma Ltd.
Exhibit 124: Aurobindo Pharma Ltd. - Overview
Exhibit 125: Aurobindo Pharma Ltd. - Product/Service
Exhibit 126: Aurobindo Pharma Ltd. - Key offerings
12.8 Bayer AG
Exhibit 127: Bayer AG - Overview
Exhibit 128: Bayer AG - Business segments
Exhibit 129: Bayer AG - Key offerings
Exhibit 130: Bayer AG - Segment focus
12.9 F. Hoffmann La Roche Ltd.
Exhibit 131: F. Hoffmann La Roche Ltd. - Overview
Exhibit 132: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 133: F. Hoffmann La Roche Ltd. - Key news
Exhibit 134: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 135: F. Hoffmann La Roche Ltd. - Segment focus
12.10 GlaxoSmithKline Plc
Exhibit 136: GlaxoSmithKline Plc - Overview
Exhibit 137: GlaxoSmithKline Plc - Business segments
Exhibit 138: GlaxoSmithKline Plc - Key offerings
Exhibit 139: GlaxoSmithKline Plc - Segment focus
12.11 Incepta Pharmaceuticals Ltd.
Exhibit 140: Incepta Pharmaceuticals Ltd. - Overview
Exhibit 141: Incepta Pharmaceuticals Ltd. - Product/Service
Exhibit 142: Incepta Pharmaceuticals Ltd. - Key offerings
12.12 Johnson and Johnson
Exhibit 143: Johnson and Johnson - Overview
Exhibit 144: Johnson and Johnson - Business segments
Exhibit 145: Johnson and Johnson - Key news
Exhibit 146: Johnson and Johnson - Key offerings
Exhibit 147: Johnson and Johnson - Segment focus
12.13 Lupin Ltd.
Exhibit 148: Lupin Ltd. - Overview
Exhibit 149: Lupin Ltd. - Product/Service
Exhibit 150: Lupin Ltd. - Key news
Exhibit 151: Lupin Ltd. - Key offerings
12.14 Mayne Pharma Group Ltd.
Exhibit 152: Mayne Pharma Group Ltd. - Overview
Exhibit 153: Mayne Pharma Group Ltd. - Business segments
Exhibit 154: Mayne Pharma Group Ltd. - Key offerings
Exhibit 155: Mayne Pharma Group Ltd. - Segment focus
12.15 Merck KGaA
Exhibit 156: Merck KGaA - Overview
Exhibit 157: Merck KGaA - Business segments
Exhibit 158: Merck KGaA - Key news
Exhibit 159: Merck KGaA - Key offerings
Exhibit 160: Merck KGaA - Segment focus
12.16 Pfizer Inc.
Exhibit 161: Pfizer Inc. - Overview
Exhibit 162: Pfizer Inc. - Product/Service
Exhibit 163: Pfizer Inc. - Key news
Exhibit 164: Pfizer Inc. - Key offerings
12.17 Sanofi SA
Exhibit 165: Sanofi SA - Overview
Exhibit 166: Sanofi SA - Business segments
Exhibit 167: Sanofi SA - Key news
Exhibit 168: Sanofi SA - Key offerings
Exhibit 169: Sanofi SA - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 170: Inclusions checklist
Exhibit 171: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 172: Currency conversion rates for US$
13.4 Research methodology
Exhibit 173: Research methodology
Exhibit 174: Validation techniques employed for market sizing
Exhibit 175: Information sources
13.5 List of abbreviations
Exhibit 176: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Vendor Market Positioning
Exhibits 10: Parent market
Exhibits 11: Market Characteristics
Exhibits 12: Offerings of vendors included in the market definition
Exhibits 13: Market segments
Exhibits 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibits 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits 18: Historic Market Size - Data Table on Global antibiotics market 2017 - 2021 ($ million)
Exhibits 19: Historic Market Size - Product Segment 2017 - 2021 ($ million)
Exhibits 20: Historic Market Size - Route of administration Segment 2017 - 2021 ($ million)
Exhibits 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
Exhibits 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)
Exhibits 23: Five forces analysis - Comparison between 2022 and 2027
Exhibits 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
Exhibits 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
Exhibits 26: Threat of new entrants - Impact of key factors in 2022 and 2027
Exhibits 27: Threat of substitutes - Impact of key factors in 2022 and 2027
Exhibits 28: Threat of rivalry - Impact of key factors in 2022 and 2027
Exhibits 29: Chart on Market condition - Five forces 2022 and 2027
Exhibits 30: Chart on Product - Market share 2022-2027 (%)
Exhibits 31: Data Table on Product - Market share 2022-2027 (%)
Exhibits 32: Chart on Comparison by Product
Exhibits 33: Data Table on Comparison by Product
Exhibits 34: Chart on Broad-spectrum antibiotics - Market size and forecast 2022-2027 ($ million)
Exhibits 35: Data Table on Broad-spectrum antibiotics - Market size and forecast 2022-2027 ($ million)
Exhibits 36: Chart on Broad-spectrum antibiotics - Year-over-year growth 2022-2027 (%)
Exhibits 37: Data Table on Broad-spectrum antibiotics - Year-over-year growth 2022-2027 (%)
Exhibits 38: Chart on Narrow-spectrum antibiotics - Market size and forecast 2022-2027 ($ million)
Exhibits 39: Data Table on Narrow-spectrum antibiotics - Market size and forecast 2022-2027 ($ million)
Exhibits 40: Chart on Narrow-spectrum antibiotics - Year-over-year growth 2022-2027 (%)
Exhibits 41: Data Table on Narrow-spectrum antibiotics - Year-over-year growth 2022-2027 (%)
Exhibits 42: Market opportunity by Product ($ million)
Exhibits 43: Chart on Route of Administration - Market share 2022-2027 (%)
Exhibits 44: Data Table on Route of Administration - Market share 2022-2027 (%)
Exhibits 45: Chart on Comparison by Route of Administration
Exhibits 46: Data Table on Comparison by Route of Administration
Exhibits 47: Chart on Intravenous - Market size and forecast 2022-2027 ($ million)
Exhibits 48: Data Table on Intravenous - Market size and forecast 2022-2027 ($ million)
Exhibits 49: Chart on Intravenous - Year-over-year growth 2022-2027 (%)
Exhibits 50: Data Table on Intravenous - Year-over-year growth 2022-2027 (%)
Exhibits 51: Chart on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits 52: Data Table on Oral - Market size and forecast 2022-2027 ($ million)
Exhibits 53: Chart on Oral - Year-over-year growth 2022-2027 (%)
Exhibits 54: Data Table on Oral - Year-over-year growth 2022-2027 (%)
Exhibits 55: Chart on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 56: Data Table on Others - Market size and forecast 2022-2027 ($ million)
Exhibits 57: Chart on Others - Year-over-year growth 2022-2027 (%)
Exhibits 58: Data Table on Others - Year-over-year growth 2022-2027 (%)
Exhibits 59: Market opportunity by Route of Administration ($ million)
Exhibits 60: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 61: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 62: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits 63: Chart on Geographic comparison
Exhibits 64: Data Table on Geographic comparison
Exhibits 65: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 66: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibits 67: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 68: Data Table on Asia - Year-over-year growth 2022-2027 (%)
Exhibits 69: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 70: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibits 71: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibits 72: Data Table on North America - Year-over-year growth 2022-2027 (%)
Exhibits 73: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 74: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibits 75: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 76: Data Table on Europe - Year-over-year growth 2022-2027 (%)
Exhibits 77: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 78: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibits 79: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 80: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibits 81: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibits 82: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibits 83: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibits 84: Data Table on US - Year-over-year growth 2022-2027 (%)
Exhibits 85: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibits 86: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibits 87: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibits 88: Data Table on China - Year-over-year growth 2022-2027 (%)
Exhibits 89: Chart on India - Market size and forecast 2022-2027 ($ million)
Exhibits 90: Data Table on India - Market size and forecast 2022-2027 ($ million)
Exhibits 91: Chart on India - Year-over-year growth 2022-2027 (%)
Exhibits 92: Data Table on India - Year-over-year growth 2022-2027 (%)
Exhibits 93: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 94: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibits 95: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibits 96: Data Table on UK - Year-over-year growth 2022-2027 (%)
Exhibits 97: Chart on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 98: Data Table on Japan - Market size and forecast 2022-2027 ($ million)
Exhibits 99: Chart on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 100: Data Table on Japan - Year-over-year growth 2022-2027 (%)
Exhibits 101: Market opportunity By Geographical Landscape ($ million)
Exhibits 102: Impact of drivers and challenges in 2022 and 2027
Exhibits 103: Overview on Criticality of inputs and Factors of differentiation
Exhibits 104: Overview on factors of disruption
Exhibits 105: Impact of key risks on business
Exhibits 106: Vendors covered
Exhibits 107: Matrix on vendor position and classification
Exhibits 108: Abbott Laboratories - Overview
Exhibits 109: Abbott Laboratories - Business segments
Exhibits 110: Abbott Laboratories - Key news
Exhibits 111: Abbott Laboratories - Key offerings
Exhibits 112: Abbott Laboratories - Segment focus
Exhibits 113: AbbVie Inc. - Overview
Exhibits 114: AbbVie Inc. - Product/Service
Exhibits 115: AbbVie Inc. - Key news
Exhibits 116: AbbVie Inc. - Key offerings
Exhibits 117: Aspen Pharmacare Holdings Ltd - Overview
Exhibits 118: Aspen Pharmacare Holdings Ltd - Business segments
Exhibits 119: Aspen Pharmacare Holdings Ltd - Key offerings
Exhibits 120: Aspen Pharmacare Holdings Ltd - Segment focus
Exhibits 121: Astellas Pharma Inc. - Overview
Exhibits 122: Astellas Pharma Inc. - Product/Service
Exhibits 123: Astellas Pharma Inc. - Key offerings
Exhibits 124: Aurobindo Pharma Ltd. - Overview
Exhibits 125: Aurobindo Pharma Ltd. - Product/Service
Exhibits 126: Aurobindo Pharma Ltd. - Key offerings
Exhibits 127: Bayer AG - Overview
Exhibits 128: Bayer AG - Business segments
Exhibits 129: Bayer AG - Key offerings
Exhibits 130: Bayer AG - Segment focus
Exhibits 131: F. Hoffmann La Roche Ltd. - Overview
Exhibits 132: F. Hoffmann La Roche Ltd. - Business segments
Exhibits 133: F. Hoffmann La Roche Ltd. - Key news
Exhibits 134: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits 135: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits 136: GlaxoSmithKline Plc - Overview
Exhibits 137: GlaxoSmithKline Plc - Business segments
Exhibits 138: GlaxoSmithKline Plc - Key offerings
Exhibits 139: GlaxoSmithKline Plc - Segment focus
Exhibits 140: Incepta Pharmaceuticals Ltd. - Overview
Exhibits 141: Incepta Pharmaceuticals Ltd. - Product/Service
Exhibits 142: Incepta Pharmaceuticals Ltd. - Key offerings
Exhibits 143: Johnson and Johnson - Overview
Exhibits 144: Johnson and Johnson - Business segments
Exhibits 145: Johnson and Johnson - Key news
Exhibits 146: Johnson and Johnson - Key offerings
Exhibits 147: Johnson and Johnson - Segment focus
Exhibits 148: Lupin Ltd. - Overview
Exhibits 149: Lupin Ltd. - Product/Service
Exhibits 150: Lupin Ltd. - Key news
Exhibits 151: Lupin Ltd. - Key offerings
Exhibits 152: Mayne Pharma Group Ltd. - Overview
Exhibits 153: Mayne Pharma Group Ltd. - Business segments
Exhibits 154: Mayne Pharma Group Ltd. - Key offerings
Exhibits 155: Mayne Pharma Group Ltd. - Segment focus
Exhibits 156: Merck KGaA - Overview
Exhibits 157: Merck KGaA - Business segments
Exhibits 158: Merck KGaA - Key news
Exhibits 159: Merck KGaA - Key offerings
Exhibits 160: Merck KGaA - Segment focus
Exhibits 161: Pfizer Inc. - Overview
Exhibits 162: Pfizer Inc. - Product/Service
Exhibits 163: Pfizer Inc. - Key news
Exhibits 164: Pfizer Inc. - Key offerings
Exhibits 165: Sanofi SA - Overview
Exhibits 166: Sanofi SA - Business segments
Exhibits 167: Sanofi SA - Key news
Exhibits 168: Sanofi SA - Key offerings
Exhibits 169: Sanofi SA - Segment focus
Exhibits 170: Inclusions checklist
Exhibits 171: Exclusions checklist
Exhibits 172: Currency conversion rates for US$
Exhibits 173: Research methodology
Exhibits 174: Validation techniques employed for market sizing
Exhibits 175: Information sources
Exhibits 176: List of abbreviations

Executive Summary

The publisher recognizes the following companies as the key players in the global antibiotics market: Abbott Laboratories, AbbVie Inc., Armata Pharmaceuticals Inc., Aspen Pharmacare Holdings Ltd, Astellas Pharma Inc., Aurobindo Pharma Ltd., Bayer AG, F. Hoffmann La Roche Ltd., Flynn Pharma Ltd., GlaxoSmithKline Plc, Incepta Pharmaceuticals Ltd., Johnson and Johnson, Lupin Ltd., Mayne Pharma Group Ltd., Melinta Therapeutics LLC, Merck KGaA, Pfizer Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., and Teva Pharmaceutical Industries Ltd.

Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is strategic alliances and mergers and acquisitions (M&A).`

According to the report, one of the major drivers for this market is the rising prevalence of infectious diseases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • AbbVie Inc.
  • Armata Pharmaceuticals Inc.
  • Aspen Pharmacare Holdings Ltd
  • Astellas Pharma Inc.
  • Aurobindo Pharma Ltd.
  • Bayer AG
  • F. Hoffmann La Roche Ltd.
  • Flynn Pharma Ltd.
  • GlaxoSmithKline Plc
  • Incepta Pharmaceuticals Ltd.
  • Johnson and Johnson
  • Lupin Ltd.
  • Mayne Pharma Group Ltd.
  • Melinta Therapeutics LLC
  • Merck KGaA
  • Pfizer Inc.
  • Sanofi SA
  • Takeda Pharmaceutical Co. Ltd.
  • Teva Pharmaceutical Industries Ltd.